
ICICI Life Q2 Results: Despite a Good Quarter, Investors Must Watch These Risks
ICICI Life Q2 results (FY27): standalone profit Rs 374.22 crore (+24.8%), VNB Rs 712 crore (+20.7%), VNB margin 25.43%, APE Rs 2,799 crore (+16.6%). Share price about Rs 453 on 14 Oct 2026 (12:40 pm), up about 1.4%. Market cap about Rs 65,770 crore. Several brokerages said the margin missed their estimates.
Updated: 14 Oct 2026 • 3:04 pm
Posted by:

Quick Answer
The ICICI Life Q2 results were good on growth, with standalone profit up 24.8% to Rs 374.22 crore, value of new business up 20.7% to Rs 712 crore and annualised premium equivalent up 16.6% to Rs 2,799 crore. The risk is the VNB margin of 25.43%, which rose from 24% a year ago but fell short of some broker estimates and slipped from the strong first quarter. Brokerages differ on the quality of growth, with one citing a higher group business mix and another a favourable product mix. Investors should watch the margin, the protection share and group business before treating the quarter as a clean beat.
ICICI Prudential Life Insurance, referred to by some sources as ICICI Life, reported its September quarter numbers on 13 October 2026, and the ICICI Life Q2 results drew mixed broker views. The stock rose as much as about 3% on 14 October before settling lower in the day.
This guide explains the ICICI Life Q2 results, the VNB margin debate, what the brokerages said and the risks to watch. Where I calculate a figure myself, I label it.
A good headline quarter can hide a weaker mix, so the margin and channel details in the ICICI Life Q2 results matter for the next few quarters.
Click Here – Get Free Investment Predictions
ICICI Life Q2 Results: Key Numbers
| Item | Q2 FY27 | Year earlier | Change |
|---|---|---|---|
| Standalone net profit | Rs 374.22 crore | Rs 299.96 crore | +24.8% |
| Value of new business (VNB) | Rs 712 crore | Rs 590 crore | +20.7% |
| Annualised premium equivalent (APE) | Rs 2,799 crore | Rs 2,400 crore | +16.6% |
| Net premium income | Rs 13,803.90 crore | Rs 11,843.10 crore | +16.6% |
| VNB margin | 25.43% | 24% | About 1.4 points higher (my calculation) |
| First half profit | Rs 760 crore | Rs 601 crore | +26.5% |
| First half VNB | Rs 1,283 crore | Rs 1,049 crore | +22.3% |
| Assets under management | Rs 3.29 lakh crore | Not given | As of 30 Sep 2026 |
The ICICI Life Q2 results show profit growth ahead of premium growth, and the first half VNB margin was 26%. One report notes the profit was about Rs 7 crore below a consensus estimate of Rs 381 crore, a miss of about 1.8% (my calculation).
Risk: A small profit miss and a margin miss mean the ICICI Life Q2 results did not clearly beat expectations despite strong growth.
Screen insurance and financial stocks on the Univest Screener
VNB Margin: Beat or Miss in the ICICI Life Q2 Results?
| Source | View on VNB margin |
|---|---|
| Company | 25.43% in Q2, up from 24%; 26% in the first half |
| Nomura | 25.4% against its estimate of 26.7%, a miss |
| Consensus estimate | 25.79%, so about 0.4 points below (one report) |
| JP Morgan | Up about 100 basis points on the year but down 129 basis points on the quarter, as protection moderated |
| Jefferies | Below expectations on a higher group funds mix; cut FY27 to FY29 VNB estimates by 2% |
| Bernstein and Goldman Sachs | Credit a favourable sales or product mix for the margin gain |
The brokerages disagree on whether the margin in the ICICI Life Q2 results is good or bad because they compare against different estimates and different periods. On the year the margin improved, but on the quarter it fell, and the Q1 level appears to have been about 26.7% from JP Morgan's figures (my inference).
Sources also differ on the VNB margin gain against the previous year, with the company data implying about 1.4 points and JP Morgan saying about 1.0 point. I show both.
Risk: If the margin keeps falling from the first quarter peak, the VNB growth that supports the ICICI Life Q2 results story could slow.
Risks to Watch After the ICICI Life Q2 Results
| Risk | Why it matters | Raised by |
|---|---|---|
| Margin moderation | Margin fell on the quarter after a strong Q1 | JP Morgan |
| Group business mix | Group funds carry lower margins and led APE growth | Jefferies |
| Protection mix | Lower retail protection cut the margin and the estimates | Jefferies, JP Morgan |
| Uneven growth | Strong in retail protection, annuities and partnerships, weaker elsewhere | Bernstein |
| Channel growth | The company may grow slower than agency channels | Nomura |
| Top line caution | Analysts cautious on premium forecasts | Goldman Sachs |
In the ICICI Life Q2 results, non-participating products are gaining share, and these usually carry different margins from protection. Because the mix drives the margin, a shift away from protection can pull VNB growth below APE growth in later quarters.
The brokerage ratings and target prices after the ICICI Life Q2 results were not given in the reports I found, so I do not quote any.
Risk: Equity market weakness can hurt linked product sales, and a fall in the share price can follow even when the ICICI Life Q2 results look good.
Download the Univest iOS App or Univest Android App to track ICICI Life and get result alerts.
What to Watch Next After the ICICI Life Q2 Results
- The VNB margin in Q3 FY27 against the 25.43% in Q2 and the 26% first half level
- The share of protection and group business in APE
- Whether brokerages cut or raise VNB estimates after the quarter
- Growth of the agency and partnership channels
- The share price against the Rs 460 intraday high on 14 October
Conclusion
The ICICI Life Q2 results show strong growth in profit, VNB and APE, but the margin and the mix behind it are the risks to follow. Investors should watch the VNB margin and the protection share before concluding that the quarter was a clean beat.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What were the ICICI Life Q2 results?
Ans. Standalone profit was Rs 374.22 crore, up 24.8%, with VNB of Rs 712 crore, up 20.7%, and APE of Rs 2,799 crore, up 16.6%.
What was the VNB margin in Q2?
Ans. The VNB margin was 25.43% in Q2, up from 24% a year earlier, and 26% in the first half.
Did the ICICI Life Q2 results miss estimates?
Ans. The VNB margin missed some broker estimates, including Nomura at 26.7% and a consensus of 25.79% in one report, and profit was about 1.8% below a Rs 381 crore estimate.
What did the brokerages say?
Ans. Nomura and JP Morgan saw a margin miss, Jefferies cited group mix and cut estimates by 2%, and Bernstein and Goldman Sachs credited a favourable mix.
What are the main risks after the ICICI Life Q2 results?
Ans. Margin moderation, a lower protection mix, group business share, uneven growth and caution on top line growth.
How did the ICICI Life share price react?
Ans. It rose as much as about 3% to Rs 460.20 on 14 October and traded near Rs 453 around midday.
What is the assets under management of ICICI Life?
Ans. Assets under management were Rs 3.29 lakh crore as of 30 September 2026.
Is this article investment advice?
Ans. No. It is educational and not a recommendation.
Recent Articles

Atal Realtech Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 14 October 2026
14 October 2026

Indosolar Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 14 October 2026
14 October 2026

Asston Pharmaceuticals Ltd. Hits Upper Circuit on BSE, 14 October 2026
14 October 2026

AVP Infracon Ltd. Hits Upper Circuit on NSE, 14 October 2026
14 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Atal Realtech Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 14 October 2026
Indosolar Ltd. Hits Upper Circuit for the 2nd Straight Session on BSE, 14 October 2026
Asston Pharmaceuticals Ltd. Hits Upper Circuit on BSE, 14 October 2026
AVP Infracon Ltd. Hits Upper Circuit on NSE, 14 October 2026
Zota Health Care Ltd. (ZOTA) Share Price rises 8.98% as stock trades at Rs 1,418
Popular this week
Fedbank Financial Services (FEDFINA) Share Price Rises 5.87% Today

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





